Tagged with AMIIF

Cristobal Thompson – Executive Director, Mexican Association of Pharmaceutical Research Industries (AMIIF)

Mexico Cristobal Thompson – Executive Director, Mexican Association of Pharmaceutical Research Industries (AMIIF)

Mexico The Mexican Association of Pharmaceutical Research Industries (AMIIF) represents the innovative pharmaceutical industry in Mexico, advocating for innovation and promoting dialogue with local authorities. AMIIF’s Executive Director, Cristobal Thompson, discusses the country and the organization’s response to the COVID-19 pandemic and outlines Mexico’s healthcare challenges and how they have evolved…

Hot Topics in Mexican Pharma

Mexico Hot Topics in Mexican Pharma

Mexico Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences industry, from the leaders of multinational affiliates, start-up entrepreneurs, association heads, and key opinion leaders. Here, we round up three of their most talked about topics. Government One of the most talked-about…

Cristóbal Thompson – Executive Director, AMIIF, Mexico

Mexico Cristóbal Thompson – Executive Director, AMIIF, Mexico

Mexico In the historic year of their 70th anniversary, Cristóbal Thompson, executive director of the Asociación Mexicana de Industrias de Investigación Farmacéutica (AMIIF), the association for research-based pharmaceutical companies in Mexico, shares their new agenda, AMIIF 2030, which aligns with the UN 2030 Agenda for Sustainable Development with a focus on…

Mexican Pharma Roundup: February 2020

Mexico Mexican Pharma Roundup: February 2020

Mexico Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is prioritising, latest news on the INSABI program, cancer research, and the lack of coronavirus expertise in Mexico. Zero tolerance for corruption: the Mexican pharma sector must…

Fighting Corruption in Mexican Pharma

Mexico Fighting Corruption in Mexican Pharma

Mexico Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption, the areas in which urgent improvement is still needed, and outlines the three key reasons why fighting corrupt practices is so important. The pharmaceutical industry must act according to value-based codes, building…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page